What is the testing modality of choice for HSV meningoencephalitis?

What is the testing modality of choice for HSV meningoencephalitis?

• A. PCR testing of the CSF
• B. MRI brain
• C. Blood culture
• D. CSF culture

Answer: (A)

The key point is that testing cerebrospinal fluid with PCR for HSV DNA is the best diagnostic modality for suspected HSV encephalitis. This test is highly sensitive and specific, and it provides rapid confirmation, which is crucial because HSV encephalitis is a medical emergency where timely antiviral treatment makes a big difference in outcomes. CSF PCR can detect HSV DNA even when viral loads are low, and it outperforms CSF culture, which is slower and less reliable for this infection. MRI of the brain can show characteristic temporal lobe involvement and support the diagnosis, but it is not definitive on its own and should not replace CSF testing. Blood cultures don’t help diagnose HSV encephalitis. In practice, you would start empiric IV acyclovir if HSV encephalitis is suspected, while obtaining CSF for PCR results to confirm the diagnosis and guide the duration of therapy. A negative PCR does not completely rule out early disease, so clinical judgment remains important.

The key point is that testing cerebrospinal fluid with PCR for HSV DNA is the best diagnostic modality for suspected HSV encephalitis. This test is highly sensitive and specific, and it provides rapid confirmation, which is crucial because HSV encephalitis is a medical emergency where timely antiviral treatment makes a big difference in outcomes.

CSF PCR can detect HSV DNA even when viral loads are low, and it outperforms CSF culture, which is slower and less reliable for this infection. MRI of the brain can show characteristic temporal lobe involvement and support the diagnosis, but it is not definitive on its own and should not replace CSF testing. Blood cultures don’t help diagnose HSV encephalitis.

In practice, you would start empiric IV acyclovir if HSV encephalitis is suspected, while obtaining CSF for PCR results to confirm the diagnosis and guide the duration of therapy. A negative PCR does not completely rule out early disease, so clinical judgment remains important.